CTOs on the Move

ACS Solutions

www.acsicorp.com

 
Founded in 1998 and headquartered in Atlanta (Duluth), Georgia, ACS Solutions employs approximately 30,000 professionals worldwide and reports an annual revenue approaching $2B. Through global delivery centers across North America, Asia, and Europe, ACS delivers strategic technology and business transformation solutions to its clients, enabling them to operate as leaders within their fields.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.acsicorp.com
  • 2400 Meadowbrook Parkway
    Duluth, GA USA 30096
  • Phone: 770.493.5588

Executives

Name Title Contact Details
Mike Dietrich
Global Chief Information Officer Profile

Similar Companies

Walnut Park Productions

Walnut Park Productions is a New York, NY-based company in the Computers and Electronics sector.

Marsh ClearSight

ClearSight is now part of Riskonnects growing suite of integrated risk management technology solutions. The combined organization joins ClearSight’s deep industry experience, long history, and global scale with Riskonnects strong integrated risk management capabilities. The new Riskonnect helps you holistically understand, manage, and control risks like never before.

Aperture

Aperture - Smarter Networks. Better Provider Relationships. Transform your provider lifecycle and network management with Aperture Health’s integrated network solutions suite.

3t Systems

3t Systems is a Greenwood Vlg, CO-based company in the Computers and Electronics sector.

Saama

Saama develops life science solutions that accelerate clinical and commercial development. Today, more than 50 biotech companies – including many of the top 20 pharmaceutical companies – use Saama`s award-winning Life Science Analytics Cloud (LSAC) platform to accelerate more than 1,500 studies, including the clinical trial led to the world`s first COVID-19 vaccine. LSAC`s rich applications facilitate unprecedented and authoritative oversight and automation of comprehensive clinical research data, enabling companies to file New Drug Application (NDAs) more efficiently and bring treatments to patients sooner.